Health Care [ 12/12 ] | Biotechnology [ 62/74 ]
NASDAQ | Common Stock
Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products.
The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products.
It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications.
The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021.
Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 13, 24 | -0.14 Decreased by -75.00% | -0.03 Decreased by -366.67% |
| Oct 13, 23 | -0.20 Decreased by -122.22% | -0.16 Decreased by -25.00% |
| Aug 30, 23 | -0.19 | -0.19 |
| May 10, 23 | -0.30 | - |
| Feb 6, 23 | -0.08 | - |
| Mar 4, 22 | -0.09 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 23 | 9.68 K Increased by +N/A% | -2.81 M Decreased by -109.77% | Decreased by -29.03 K% Decreased by N/A% |
| Sep 30, 23 | 7.05 K Increased by +N/A% | -2.58 M Decreased by -34.58% | Decreased by -36.56 K% Decreased by N/A% |
| Jun 30, 23 | 7.05 K Increased by +N/A% | -2.58 M Decreased by -96.25% | Decreased by -36.56 K% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -5.29 M Decreased by -216.63% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -1.34 M Increased by +12.57% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 - | -1.91 M - | Decreased by N/A% - |
| Jun 30, 22 | 0.00 - | -1.31 M - | Decreased by N/A% - |
| Mar 31, 22 | 0.00 - | -1.67 M - | Decreased by N/A% - |